Surprising Clinical Trial Results in Pancreatic and Rectal Cancer
Let’s Win Scientific Advisory Board Chair Dr. Allyson Ocean explains the surprising clinical trial results in pancreatic and rectal cancers.
A New Immunotherapy Combination for Metastatic Pancreatic Cancer
Researchers are looking at a combination of two types of monoclonal antibodies to treat advanced pancreatic cancer.
Improving Access to Genetic Testing and Counseling
Dr. Angela Bradbury is leading a study on access to genetic testing and genetic counseling, including a telehealth option.
Lustgarten Foundation Receives $424,000 Grant Establishing the Gail V. Coleman and Kenneth M. Bruntel Organoids for Personalized Therapy Project
The Lustgarten Foundation has received a grant for their Organoids for Personalized Therapy program.
GENERATE Trial Expands Eligibility
Dr. Sapna Syngal explains the expanded eligibility standards for the GENERATE Study for genetic testing of pancreatic cancer patients and relatives.
PARP Inhibitors in Pancreatic Cancer
Tanios Bekaii-Saab, M.D., of the Mayo Clinic in Phoenix, AZ, explains the importance of research into treatment with PARP inhibitors in a short and informative video. Watch the video . . .
IARC Identifies Eight Additional Cancer Sites Linked to Overweight and Obesity
Based on a systematic review of the published scientific literature, the Working Group for IARC Handbooks of Cancer Prevention Volume 16: Body Fatness provided the latest evaluation of the cancer-preventive effects of the absence of excess body fatness. A summary of the results is published today in The New England Journal of Medicine. A Working…
Pancreatic Cancer Trial to Make Tumors More Sensitive to Treatment
The trial, which launches in the UK today, will treat pancreatic cancer patients whose cancer has grown too big to be removed by surgery but has not yet spread to other parts of the body. The team will give patients on the trial a drug called olaparib, in addition to the standard treatment of chemotherapy…